webinar register page

Webinar banner
Seagen R&D Day
The event will include discussion of the broad clinical development of Seagen’s marketed products, ADCETRIS®, PADCEV® and TUKYSA®, as well as an overview of its deep pipeline of innovative therapies for cancer.

Speakers will include the following from Seagen:

Clay Siegall, Ph.D., President and CEO
Roger Dansey, M.D., Chief Medical Officer
Other leaders from the Company’s development team

Nov 16, 2020 10:00 AM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Seagen Investor Relations.